©The Author(s) 2025.
World J Clin Oncol. Oct 24, 2025; 16(10): 110047
Published online Oct 24, 2025. doi: 10.5306/wjco.v16.i10.110047
Published online Oct 24, 2025. doi: 10.5306/wjco.v16.i10.110047
Table 3 The information of patients with intravesical recurrence after radical nephroureterectomy
| Variable | n (%) |
| All | 14 |
| Gender | |
| Male | 7 (50) |
| Female | 7 (50) |
| Grade | |
| Low | 4 (29) |
| High | 10 (71) |
| Tumor location | |
| Ureter | 8 (57) |
| Renal pelvis | 6 (43) |
| HER2 | |
| Negative | 9 (64) |
| Positive | 5 (36) |
| Stage | |
| ≤ T1 | 4 (29) |
| T2 | 1 (7) |
| ≥ T3 | 9 (64) |
| Molecular subtype | |
| Luminal | 10 (71) |
| Basal | 4 (29) |
- Citation: Huang L, He J. Human epidermal growth factor receptor 2 overexpression is associated with high-grade tumors in upper tract urothelial carcinoma. World J Clin Oncol 2025; 16(10): 110047
- URL: https://www.wjgnet.com/2218-4333/full/v16/i10/110047.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i10.110047